Gilde Healthcare has invested in Tandarts Today
Gilde Healthcare has invested in Tandarts Today, a fast-growing dental chain in the Netherlands. The investment will allow Tandarts Today to accelerate its buy-and-build strategy and become a leading dental chain in the Netherlands. Financial details have not been disclosed.
Tandarts Today, founded in 2015, offers all disciplines of regular dentistry, including special treatments such as implantology, orthodontics, periodontology and aesthetic treatments. Furthermore, through its own dental laboratories, it develops hockey bits, custom-made prostheses, bridges and other dental work pieces.
Gilde Healthcare is a specialized European healthcare investor managing over US$1.5 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in health tech and therapeutics. The venture & growth companies are based in Europe and North America. Gilde Healthcare’s private equity fund invests in profitable European lower mid-market healthcare companies, with a focus on the Benelux and DACH regions. The private equity fund targets healthcare, suppliers of medical products and service providers in the healthcare market.
Oaklins’ team in the Netherlands acted as the exclusive financial advisor to the seller in this transaction.



Ruben Hoefnagels
Founder and CEO, Tandarts Today
Sprechen Sie mit dem Deal-Team
Sander van 't Spijker
Oaklins Netherlands
Transaktionen
Main Capital Partners has acquired a majority stake in CarWise and AutoDisk
CarWise and AutoDisk (together “CarWise”), leading providers of integrated front-, mid- and back-office ERP software for the leasing and car rental sector in the Benelux, have sold a majority stake to Main Capital Partners (“Main”), a prominent European software investor.
Mehr erfahrenRAM Infotechnology has acquired Interoperability Group with support from Keensight Capital
RAM Infotechnology (RAM-IT) has acquired Interoperability Group, a leading Dutch provider of healthcare IT solutions, with the support of Keensight Capital, a leading European growth buy-out investor specializing in technology and healthcare.
Mehr erfahrenTages Capital SGR has acquired two RTB biomethane plants from Finpower Project
Tages Capital SGR, through its fund Tages Helios Net Zero, has acquired a portfolio consisting of two ready-to-build (RTB) biomethane plants located in Southern Italy.
Mehr erfahren